JoshuaJamesMooneyMDMS

Pulmonology • Palo Alto, CA

Critical Care Medicine, Interstitial Lung Diseases, Lung Transplantation Medicine

Clinical Assistant Professor

Join to view full profile

Dr. Mooney is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mooney's full profile

Already have an account?

Office
300 Pasteur Dr
Palo Alto, CA 94305
Phone+1 650-736-5400

Fax+1 650-498-5840

Summary

Dr. Joshua Mooney is a pulmonologist in Palo Alto, CA and is affiliated with Stanford Health Care. He received his medical degree from University of Minnesota Medical School and has been in practice 8 years. He specializes in critical care medicine, interstitial lung diseases, lung transplantation medicine, and pleural disease.

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2012 - 2015
University of California (San Francisco)Residency, Internal Medicine, 2009 - 2012
University of Minnesota Medical SchoolClass of 2009

Certifications & Licensure

CA State Medical License 2010 - 2026
NV State Medical License 2015 - 2025

Clinical Trials

A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis Start of enrollment: 2017 Jul 26
Terminated
Phase 2
A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis Start of enrollment: 2017 Nov 27
Completed
Phase 3

Publications & Presentations

PubMed

Bexotegrast Shows Dose-dependent Integrin αβReceptor Occupancy in Lungs of Participants with Idiopathic Pulmonary Fibrosis: A Phase 2, Open-Label Clinical Trial.
Joshua J Mooney, Susan Jacobs, Éric A Lefebvre, Gregory P Cosgrove, Annie Clark
Annals of the American Thoracic Society. 2024-11-05
6 citations
A double-blind, placebo-controlled, randomized withdrawal trial of sarilumab for the treatment of glucocorticoid-dependent sarcoidosis.
Matthew C Baker, Audra Horomanski, Yiwen Wang, Yuhan Liu, Shima Parsafar
Rheumatology. 2024-05-02
A Machine Learning System to Indicate Diagnosis of Idiopathic Pulmonary Fibrosis Non-Invasively in Challenging Cases.
Yousef Ahmad, Joshua Mooney, Isabel E Allen, Julia Seaman, Angad Kalra
Diagnostics. 2024-04-17

Press Mentions

Triple-Organ Recipient Joins Walk to Promote Organ DonationMarch 26th, 2021
Should BAL Be Routinely Performed in the Diagnostic Evaluation of IPF?November 22nd, 2017
High-Volume Lung Transplant Centers Have Lower Costs and ReadmissionsApril 14th, 2016